Takashi Yamaguchi

Takashi Yamaguchi

Auto-generated profile, based on publicly available information

Takashi Yamaguchi

Department of Palliative Care Konan Medical Center Kobe Japan

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Maternal and Child Health Journal
Verified
Journal Article
Open access
PDF file
KOKeiko Otsuka
Keiko Otsuka
MTMasataka Taguri
Masataka Taguri
CDCindy-Lee Dennis
Cindy-Lee Dennis
KWKiriko Wakutani
Kiriko Wakutani
MAMasayo Awano
Masayo Awano
MJMasamine Jimba
Masamine Jimba
Breastfeeding self-efficacy interventions are important for improving breastfeeding outcomes. However, the circumstances that may influence the effectiveness of the interventions are unclear, especially in the context of hospitals with suboptimal infant feeding practices. Thus, we aimed to evaluate the effect of a self-efficacy intervention on breastfeeding self-efficacy and exclusive breastfeeding, and further assessed the difference in its effect by hospital-routine type. In this intervention study with a control group, 781 pregnant women were recruited from 2 “Baby-Friendly”-certified hospitals (BFH) and 2 non-Baby-Friendly Hospitals (nBFH) in Japan, and were allocated to an intervention or control group. Participants in the intervention group were provided with a breastfeeding self-efficacy workbook in their third trimester. The primary outcome was breastfeeding self-efficacy and the secondary outcome was infant feeding status. All analyses were stratified by the type of hospital, BFH or nBFH. In BFHs, the intervention improved both breastfeeding self-efficacy through 4 weeks postpartum (p = 0.037) and the exclusive breastfeeding rate at 4 weeks postpartum (AOR 2.32, 95 % CI 1.01–5.33). In nBFHs, however, no positive effect was observed on breastfeeding self-efficacy (p = 0.982) or on the exclusive breastfeeding rate at 4 weeks postpartum (AOR 0.97, 95 % CI 0.52–1.81); in nBFHs, supplementation was provided for breastfed infants and the mother and infant were separated in the vast majority of cases. Infant feeding status at 12 weeks was not improved in either hospital type. The intervention improved breastfeeding self-efficacy and exclusive breastfeeding at 4 weeks postpartum only in BFHs. When breastfeeding self-efficacy interventions are implemented, hospital infant feeding practices may need to be optimized beforehand.


1 July 2017 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
TYTakashi Yamaguchi
Takashi Yamaguchi
IMIsseki Maeda
Isseki Maeda
YHYutaka Hatano
Yutaka Hatano
MMMasanori Mori
Masanori Mori
YSYasuo Shima
Yasuo Shima
MMMitsunori Miyashita
Mitsunori Miyashita

1 January 2016 in The Lancet Oncology
Verified
Journal Article
Closed access
IMIsseki Maeda
Isseki Maeda
TMTatsuya Morita
Tatsuya Morita
TYTakuhiro Yamaguchi
Takuhiro Yamaguchi
SISatoshi Inoue
Satoshi Inoue
MIMasayuki Ikenaga
Masayuki Ikenaga
HKHiroya Kinoshita
Hiroya Kinoshita

8 June 2015 in The Oncologist
Verified
Journal Article
Open access
PDF file
JHJun Hamano
Jun Hamano
TMTatsuya Morita
Tatsuya Morita
SISatoshi Inoue
Satoshi Inoue
MIMasayuki Ikenaga
Masayuki Ikenaga
YMYoshihisa Matsumoto
Yoshihisa Matsumoto
HKHiroya Kinoshita
Hiroya Kinoshita
Background.: Predicting the short-term survival in cancer patients is an important issue for patients, family, and oncologists. Although the prognostic accuracy of the surprise question has value in 1-year mortality for cancer patients, the prognostic value for short-term survival has not been formally assessed. The primary aim of the present study was to assess the prognostic value of the surprise question for 7-day and 30-day survival in patients with advanced cancer. Patients and Methods.: The present multicenter prospective cohort study was conducted in Japan from September 2012 through April 2014, involving 16 palliative care units, 19 hospital-based palliative care teams, and 23 home-based palliative care services. Results.: We recruited 2,425 patients and included 2,361 for analysis: 912 from hospital-based palliative care teams, 895 from hospital palliative care units, and 554 from home-based palliative care services. The sensitivity, specificity, positive predictive value, and negative predictive value of the 7-day survival surprise question were 84.7% (95% confidence interval [CI], 80.7%–88.0%), 68.0% (95% CI, 67.3%–68.5%), 30.3% (95% CI, 28.9%–31.5%), and 96.4% (95% CI, 95.5%–97.2%), respectively. The sensitivity, specificity, positive predictive value, and negative predictive value for the 30-day surprise question were 95.6% (95% CI, 94.4%–96.6%), 37.0% (95% CI, 35.9%–37.9%), 57.6% (95% CI, 56.8%–58.2%), and 90.4% (95% CI, 87.7%–92.6%), respectively. Conclusion.: Surprise questions are useful for screening patients for short survival. However, the high false-positive rates do not allow clinicians to provide definitive prognosis prediction. Implications for Practice: The findings of this study indicate that clinicians can screen patients for 7- or 30-day survival using surprise questions with 90% or more sensitivity. Clinicians cannot provide accurate prognosis estimation, and all patients will not always die within the defined periods. The screened patients can be regarded as the subjects to be prepared for approaching death, and proactive discussion would be useful for such patients.

5 December 2017 in Journal of Patient-Reported Outcomes
Verified
Journal Article
Open access
PDF file
TMTempei Miyaji
Tempei Miyaji
YIYukiko Iioka
Yukiko Iioka
Yujiro KurodaYujiro Kuroda
Yujiro Kuroda
DYDaigo Yamamoto
Daigo Yamamoto
SISatoru Iwase
Satoru Iwase
TYTakuhiro Yamaguchi
Takuhiro Yamaguchi
The US National Cancer Institute (NCI) has developed the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) to capture patients’ self-reported symptomatic adverse events in cancer clinical trials. The aim of this study was to develop and linguistically validate a Japanese translation of PRO-CTCAE. Forward- and back-translations were produced, and an independent review was performed by the Japan Clinical Oncology Group (JCOG) Executive Committee and the US NCI. We then conducted cognitive interviews with 21 patients undergoing cancer treatment. Participants were asked to complete the PRO-CTCAE and were interviewed using semi-structured scripts and predetermined probes to investigate whether any items were difficult to understand or answer. The interviews were recorded and transcribed, and a thematic analysis was performed. The data were split into two categories: 1) remarks on the items and 2) remarks on the questionnaire in general. Twenty-one cancer patients undergoing chemotherapy or hormone therapy were interviewed at the University of Tokyo Hospital and the Kansai Medical University Hirakata Hospital during 2011 and 2012. Thirty-three PRO-CTCAE items were evaluated as “difficult to understand,” and 65 items were evaluated as “difficult to answer” by at least one respondent. However, on further investigation, only 24 remarks were categorized as “comprehension difficulties” or “clarity” issues. Most of these remarks concerned patients’ difficulties with rating their experience of individual symptomatic events. The study provides preliminary evidence supporting the linguistic validity of the Japanese version of PRO-CTCAE. Further cognitive interviewing is warranted for PRO-CTCAE items relating to sexuality and anxiety and for response options on severity attribute items.